KR20000000757A - Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same - Google Patents

Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same Download PDF

Info

Publication number
KR20000000757A
KR20000000757A KR1019980020576A KR19980020576A KR20000000757A KR 20000000757 A KR20000000757 A KR 20000000757A KR 1019980020576 A KR1019980020576 A KR 1019980020576A KR 19980020576 A KR19980020576 A KR 19980020576A KR 20000000757 A KR20000000757 A KR 20000000757A
Authority
KR
South Korea
Prior art keywords
growth hormone
weight
ethanol
release
reduced pressure
Prior art date
Application number
KR1019980020576A
Other languages
Korean (ko)
Inventor
배오성
Original Assignee
배오성
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 배오성 filed Critical 배오성
Priority to KR1019980020576A priority Critical patent/KR20000000757A/en
Publication of KR20000000757A publication Critical patent/KR20000000757A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

PURPOSE: A composition of herb medicine for promoting release of growth hormone is provided which has no adversary side effect compared with conventional promoting agent for release of growth hormone. CONSTITUTION: The composition comprises: 15-46 wt% of steamed Rehmannia glutinosa; 5-36 wt% of Cornusofficinalis; 5-36 wt% of white agaric; 4-35 wt% of Alisma canaliculatum; 3-34 wt% of the root of Lycium chinense, Scrophularia buergeriana, the fruit of Lycium chinense, Rubus schizostulus, Psyllium, Schizonepeta tenuifolia var. japonica, Ledebourielleseseloides, the soft core of the young antlers of the deer, a deer's horn, Cordycepssinensis, Anemarrhena asphodeloides and Phellodendron amurense respectively. A promoting agent for release of growth hormone is obtained by: mixing the components; extracting; concentrating under reduced pressure followed by cooling; making 65% ethanol solution by adding ethanol; agitating followed by filtering; concentrating again under reduced pressure followed by cooling; making 85% ethanol solution by adding ethanol; agitating followed by filtering; concentrating again under reduced pressure to evaporate the ethanol; freeze-drying; dissolving it in physiological salt solution; and filtering with milipore filter paper.

Description

성장호르몬 분비 촉진용 생약재 조성물 및 이를 이용하여 제조한 성장호르몬 분비 촉진제Herbal composition for promoting growth hormone secretion and growth hormone secretagogue prepared using the same

본 발명은 부작용이 없으면서 성장호르몬 분비를 촉진하여 성장을 유도할 수 있는 성장호르몬 분비 촉진용 생약재 조성물 및 이를 이용하여 제조한 성장호르몬 분비 촉진제에 관한 것으로, 좀 더 구체적으로는 숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피 각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것으로 각각의 성분을 세말하여 분말을 균일하게 혼합한 후, 증류수에 침전추출하고 여과한 다음, 감압농축하여 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 후, 2차감압농축하여 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차감압농축하여 증류수를 첨가하고 감압농축하여 에탄올을 완전히 증발시킨 후, 동결건조하고 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 주사액으로 제조한 것을 특징으로 하는 성장호르몬 분비 촉진용 생약재 조성물 및 이를 이용하여 제조한 성장호르몬 분비 촉진제에 관한 것이다.The present invention relates to a herbal composition for promoting growth hormone secretion that can induce growth by promoting growth hormone secretion without side effects, and a growth hormone secretagogue prepared by using the same, and more specifically 15 to 46% by weight of sulfur , Cornus and Baekbokryeong each 5 to 36% by weight, taeksa and the neck skin 4 to 35% by weight, phalanx skin, Hyunsam, Gugija, Bokbunja, tea electrons, mold opening, windproof, deer antler, green rust, Cordyceps sinensis, 3-4% It is composed of%, and each powder is uniformly mixed with powder, precipitated and extracted with distilled water, filtered, concentrated under reduced pressure and cooled, added with ethanol to make 65% ethanol solution, stirred and left at low temperature to precipitate. After filtration, the mixture was concentrated and cooled by secondary pressure reduction, ethanol was added to make an 85% ethanol solution, stirred, and left to stand at low temperature to filter the precipitate. Um, tertiary reduced pressure, distilled water is added, concentrated under reduced pressure, ethanol is completely evaporated, lyophilized, dissolved in physiological saline, filtered through Millipore filter paper, and prepared as an injection solution. It relates to a composition and a growth hormone secretagogue prepared using the same.

경제성장과 함께 식생활이 개선되면서 청소년들의 평균신장이 10여년전에 비해 크게 증가하였으나 경우에 따라서는 유전적인 요인 뿐만 아니라 후천적인 질병발생 등에 의해 성장에 장애현상을 보이는 경우가 적지 않다.As the dietary growth improved with economic growth, the average height of adolescents increased significantly compared to 10 years ago. However, in some cases, there are not many cases where growth is hindered by not only genetic factors but also acquired diseases.

따라서, 상기와 같은 왜소증 치료를 위해 유전공학 기법에 의해 대량 생산한 성장호르몬을 투여하거나 물리적으로 뼈의 일정부위를 수술 등에 의해 늘리는 방법을 사용하고 있다.Therefore, for the treatment of dwarfism as described above, a method of administering a growth hormone produced in large quantities by genetic engineering techniques or physically increasing a certain portion of bone by surgery or the like is used.

그러나, 성장 정지 이전이거나 일정한 조건에 한해서만 처방되는 이들 방법에 의한 임상결과는 때로는 심각한 부작용이 따르며, 그 기대효과 또한 크지 않을 뿐만 아니라 경제적인 부담도 적지 않다.However, clinical results by these methods, which are prescribed only before or after growth arrest, are sometimes seriously adverse, and the expected effect is not great and the economic burden is not small.

일반적으로 뇌하수체 전엽(Anterior Pituitary)에서 분비되는 성장호르몬은 소마토트로핀(Somatotropin)이라고도 하며, 몸의 성장, 발육을 촉진시키고 당질, 지방질, 단백질의 신진대사에 직접 작용하여 골격성장은 물론 내장 등의 성장 속도를 조절하는 각종 작용을 나타낸다.In general, growth hormone secreted from the anterior pituitary is also called somatotropin, which promotes the growth and development of the body and directly acts on the metabolism of sugars, fats and proteins, resulting in skeletal growth as well as intestines. It exhibits various actions to regulate the growth rate of.

그리고, 혈액중 성장흐르몬의 농도는 수면이나 스트레스 등과 같은 자극에 의해 수분내에 급격히 상승하기도 하며, 성장호르몬의 작용에 의해 그후 신장이나 간에서 생성되는 소마토메딘(Somatomedin)은 연골세포에서 콜라겐의 합성을 촉진하여 뼈를 성장시킨다.In addition, the concentration of growth hormone in the blood rises rapidly in a few minutes due to stimulation such as sleep or stress. Somatomedin, which is produced in the kidney or liver by the action of growth hormone, is the collagen of chondrocytes. Promote synthesis to grow bone.

사춘기 시절의 급성장은 성장호르몬 및 성호르몬의 분비가 증가되어 나타난다. 성장호르몬은 장골의 성장을 돕고 성호르몬은 척골의 성장을 도와주며 성장호르몬 분비에도 영향을 주기 때문에 급성장이 이루어진다고 알려져 있으며, 성장호르몬(Growth hormone)의 분비는 시상하부의 성장호르몬 방출호르몬(Growth Hormone Releasing Hormon, GHRH)에 의해 자극되며 성장호르몬 분비 억제호르몬(소마토스타틴;Somatostatin(SS))에 의해 억제된다. 또한, 지금까지 알려진 성장호르몬의 분비를 자극하거나 억제시키는 물질은 대부분 시상하부에 작용하여 GHRH와 SS의 분비를 조절하여 간접적으로 성장호르몬의 분비상태를 조절하는 것으로 알려져 있다.The rapid growth during puberty is accompanied by increased secretion of growth hormones and sex hormones. Growth hormone helps the growth of long bones, sex hormone helps the growth of the ulna, and growth hormone secretion is known to be a rapid growth, growth hormone secretion of the growth hormone (Growth hormone) growth hormone release hormone (Growth of the hypothalamus) Hormone Releasing Hormon (GHRH) and is inhibited by growth hormone secretion inhibitor hormone (somatostatin (Somatostatin (SS))). In addition, substances that stimulate or inhibit the secretion of growth hormone known to date are mostly known to act on the hypothalamus to indirectly regulate the secretion of growth hormone by controlling the secretion of GHRH and SS.

1958년 부터 성장호르몬 결핍증 환자에게 성장호르몬을 투여하기 시작하였으며, 성장호르몬이 유전공학의 발달에 의해 대량생산이 가능해짐에 따라 성장호르몬결핍증 뿐만 아니라 터너증후군, 가족성왜소증 같은 성장호르몬 비결핍성왜소증에 성장호르몬제제를 투여하기도 한다.Since 1958, growth hormone has been administered to patients with growth hormone deficiency. As growth hormone is mass-produced by the development of genetic engineering, growth hormone non-deficiency dwarfism such as Turner syndrome, familial dwarfism, as well as growth hormone deficiency In some cases, growth hormone may be administered.

그러나, 성장호르몬제제는 고관절탈구, 갑상선 기능저하증, 성장호르몬 항체형성등의 부작용을 가지고 있으며, 대량 투여시에는 당내불성(glucose intolerance)이 나타나기도 하므로 성장호르몬의 남용을 방지할 필요가 있으며, 부작용이 없으면서도 자연스럽게 성장을 유도하는 치료법의 개발이 시급한 실정이다.However, growth hormone preparations have side effects such as hip dislocation, hypothyroidism, and growth hormone antibody formation.Glucose intolerance may occur when administered in large doses, and therefore, it is necessary to prevent abuse of growth hormone. Without this, it is urgent to develop a treatment that naturally induces growth.

따라서, 본 발명의 목적은 부작용이 없으면서도 성장호르몬 분비를 촉진하여 성장을 유도할 수 있는 성장호르몬 분비 촉진용 생약재 조성물을 제공하는 데 있다.Accordingly, it is an object of the present invention to provide a herbal composition for promoting growth hormone secretion that can induce growth by promoting growth hormone secretion without side effects.

본 발명의 다른 목적은 상기 목적의 성장호르몬 분비 촉진용 생약재 조성물을 이용하여 제조한 성장호르몬 분비 촉진제를 제공하는 데 있다.Another object of the present invention to provide a growth hormone secretagogue prepared by using the herbal composition for promoting growth hormone secretion of the above object.

상기 목적들 뿐만 아니라 용이하게 표출될 수 있는 또 다른 목적을 달성하기 위하여 본 발명에서는 숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피 각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것으로 각각의 성분을 세말하여 분말을 균일하게 혼합한 후, 증류수에 침전추출하고 여과한 다음, 감압농축하여 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 후, 2차감압농축하여 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차감압농축하여 증류수를 첨가하고 감압농축하여 에탄올을 완전히 증발시킨 후, 동결건조하고 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 주사액으로 성장호르몬 분비 촉진제를 제조하고 이를 성장기 어린이 또는 왜소증 환자에 투여하므로서 성장을 촉진시킬 수 있는 효과를 얻을 수 있었다.In order to achieve the above object as well as another object that can be easily expressed in the present invention, 15 to 46% by weight of Sukjihwang, 5 to 36% by weight of cornus and Baekbokryeong, 4 to 35% by weight of taxa and neck skin, phalanges, It consists of 3 ~ 34% by weight of Hyunsam, Gugija, Bokbunja, Chajeon, Hyeonggae, Windproof, Deer Antler, Green Ginseng, Cordyceps Sinensis, Zimo, and Yellow White, and then mix the powders uniformly and settle into distilled water. After filtration and concentration, the mixture was concentrated under reduced pressure and cooled, added to ethanol to form a 65% ethanol solution, stirred, and left to stand at low temperature. The precipitate was filtered off, and then concentrated under reduced pressure to cool, and ethanol was added to make a 85% ethanol solution. The mixture was left at low temperature, filtered, and the precipitate was filtered, and then concentrated under reduced pressure. Then, distilled water was added and concentrated under reduced pressure to completely evaporate ethanol, followed by freeze drying and physiological salt. Next, the mixture was filtered through a Millipore filter paper dissolved in the producing a growth hormone secretagogue in injection solutions and this effect could be obtained that can promote the growth hameuroseo administered in growing children or dwarfism patients.

도 1 및 도 2는 실시예1에서 측정된 성장호르몬 함량을 나타내는 그래프이다.1 and 2 are graphs showing the growth hormone content measured in Example 1.

본 발명을 좀 더 구체적으로 설명하면 다음과 같다.The present invention is described in more detail as follows.

본 발명에 따른 성장호르몬 분비 촉진용 생약재 조성물은 숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피 각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것을 특징으로 한다.The herbal composition for promoting growth hormone secretion according to the present invention is 15 to 46% by weight of Sukjihwang, 5 to 36% by weight of Cornus and Baekbokryeong, 4 to 35% by weight of Taeksa and Magnolia skin, Jigolpi, Hyunsam, Gugijak, Bokbunja, Cha-jeon, It is characterized by consisting of 3 to 34% by weight of mold opening, windproof, deer antler, green shell, cordyceps sinensis, hair loss and yellowish white.

또한, 본 발명에 따른 성장호르몬 분비 촉진제는 숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피 각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것으로 각각의 성분을 세말하여 분말을 균일하게 혼합한 후, 증류수에 침전추출하고 여과한 다음, 감압농축하여 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 후,2차감압농축하여 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차감압농축하여 증류수를 첨가하고 감압농축하여 에탄올을 완전히 증발시킨 후, 동결건조하고 생리식염수에 용해한 다음, 밀리포아여과지로 여과하여 주사액으로 제조하는 것을 특징으로 한다.In addition, the growth hormone secretagogue according to the present invention 15 to 46% by weight of sukjihwang, 5 to 36% by weight of corn and baekbokryeong, 4 to 35% by weight each of talc and neck skin, Jigolpi, Hyunsam, Gugija, Bokbunja, tea and mold , Windproof, Deer Antler, Green Ginseng, Cordyceps Sinensis, Balaxia, and Yellow White, each composed of 3 to 34% by weight, each of the components are finely mixed and mixed with powder, precipitated and extracted with distilled water, filtered and concentrated under reduced pressure. Ethanol was added to make a 65% ethanol solution, stirred and left to stand at low temperature to filter the precipitate. The precipitate was concentrated and cooled. Secondary pressure reduction was added to make 85% ethanol solution. The mixture was stirred and left at low temperature to filter the precipitate. , Concentrated under reduced pressure, distilled water was added, concentrated under reduced pressure, ethanol was completely evaporated, lyophilized, dissolved in physiological saline, and then filtered through Millipore filter. It is characterized by producing a liquid.

숙지황은 현삼과에 속하는 지황(Rehmannia glutinosa)의 근경을 건조한 건지황을 증열한 것으로 자음, 보위, 보혈, 조경 등의 효능이 있고, 예로 부터 한방에서는 각종 처방에 사용되어 왔다. 본 발명에서의 숙지황 사용량은 15 ∼ 46중량%가 효과적이고, 사용량이 15중량% 미만일 경우에는 첨가 효과가 미약하고,46중량%를 초과할 경우에는 상대적으로 다른 성분의 사용량이 감소되어 본 발명에서 얻고자 하는 효과를 달성할 수 없는 문제점이 있다.Sukjihwang is the dried root of dried Guhwang (Rehmannia glutinosa) belonging to the Hyunsam family, which has the effect of consonant, bowie, blood, landscaping, etc., and has been used in various medicines from the traditional medicine. In the present invention, the amount of sulfur used in the present invention is 15 to 46% by weight, and when the amount is less than 15% by weight, the effect of addition is insignificant. There is a problem that cannot achieve the desired effect.

산수유는 산수유나무의 열매 또는 그 씨를 말린 것으로, 해열, 강장제로 많이 사용되며, 요통, 해소, 이뇨 등에도 사용되고, 본 발명에서의 사용량은 5 ∼ 36중량%가 효과적이며, 사용량이 5중량% 미만일 경우에는 첨가 효과가 미약하고, 36중량%를 초과할 경우에는 상대적으로 다른 성분의 사용량이 감소되어 본 발명에서 얻고자 하는 효과를 달성할 수 없는 단점이 있다. 백복령은 소나무과에 기생하는 구멍장이 버섯과에 속하는 일종의 균괴로서 소나무를 베어낸 썩은 나무에 기생하여 성장하고, 건비, 삼습, 안신, 생진 등의 효능이 있어 각종 질병에 많이 응용되어 왔으며, 본 발명에서의 사용량은 5 ∼ 36중량%가 효과적이며, 사용량이 5중량% 미만일 경우에는 첨가 효과가 미약하고, 36중량%를 초과할 경우에는 상대적으로 다른 성분의 사용량이 감소되어 본 발명에서 얻고자 하는 효과를 달성할 수 없는 단점이 있다.Cornus is dried fruit or seed of cornus tree, it is widely used as antipyretic, tonic, low back pain, relieves, diuretic, etc., the amount of use in the present invention is effective 5 to 36% by weight, the amount is less than 5% by weight In the case of the addition effect is weak, when the amount exceeds 36% by weight relatively has a disadvantage that the amount of the other components are reduced to achieve the effect to be obtained in the present invention. Baekbokryeong is a kind of fungus belonging to the family of fungi, which are parasitic in the pine family. They are parasitic and grow on rotten trees that have cut pine trees. 5 to 36% by weight of the effective amount of, when the amount is less than 5% by weight of the effect of the addition is weak, when the amount exceeds 36% by weight of the other components of the relatively reduced amount of the effect to obtain in the present invention There is a disadvantage that can not be achieved.

택사는 다년생 수생 초본으로서 50 ∼ 100cm 정도 자라며 잎이 구상의 형태인 택사과에 속한 질경이택사의 구경으로서, 늦가을 잎이 마른 때에 근경을 채취하여 줄기와 수염뿌리를 제거하고 깨끗이 씻은 후, 조피를 제거하고 햇볕에 건고시키거나 약한 불로 화건한 것을 사용하며, 이뇨, 지사, 청습열, 강혈지의 효과가 있고, 4∼ 35중량%를 사용하는 것이 효과적이며, 사용량이 4중량% 미만일 경우에는 첨가효과가 미약하고,35중량%를 초과할 경우에는 상대적으로 다른 성분의 사용량이 감소되어 본 발명에서 얻고자 하는 효과를 달성할 수 없는 단점이 있다.Taxa is a perennial aquatic herb that grows about 50 ~ 100cm and is a diameter of the plantain of the planar tree belonging to the celtic family whose leaves are spherical. To dry in the sun, or to use it on low heat, use diuretic, branch, moist heat, strong blood, and use 4 to 35% by weight, if the amount is less than 4% by weight, the effect of addition If the amount is less than 35% by weight, the amount of the other components is relatively reduced, so that the effect to be obtained in the present invention cannot be achieved.

목단피는 다년생 낙엽 소권목인 미나리아재비과에 속하는 모란(Paeonia suffruticosa)의 근피로서 채취하여 깨끗이 씻어 잔뿌리와 줄기 등을 제거하고 나서 목심을 제거하여 햇볕에 건조시킨 것을 사용하며, 해열, 경혈, 구어혈, 진통, 소염 등의 효능이 있는 것으로 알려져 있고, 본 발명에서는 4 ∼ 35중량%를 사용하는 것이 효과적이며, 사용량이 4중량% 미만일 경우에는 첨가 효과가 미약하고, 35중량%를 초과할 경우에는 상대적으로 다른 성분의 사용량이 감소되어 본 발명에서 얻고자하는 효과를 달성할 수 없는 단점이 있다.Bark skin is the root of Peony (Paeonia suffruticosa) belonging to the perennial deciduous subtilis, Peaonia suffruticosa, collected and washed to remove fine roots and stems, and then to remove the core and dried in the sun. It is known to have an effect such as anti-inflammatory, and in the present invention, it is effective to use 4 to 35% by weight, and when the amount of use is less than 4% by weight, the effect of addition is weak, and when it exceeds 35% by weight, There is a disadvantage in that the amount of other components used is reduced to achieve the effect desired in the present invention.

지골피는 낙엽 관목으로 가지과에 속하는 구기자 나무의 근피로서 자신, 보간, 윤폐, 자음, 명목 등의 효능이 있는 것이고, 현삼은 다년생 초본으로서 현삼과에 속하는 진현삼(Scrophularia ningpoensis) 및 동속의 근으로서 채취하여 줄기와 잔뿌리를 제거하고 깨끗이 하여 5일 정도 햇볕에 건조시켜 화건한 것을 사용하며, 자음, 강화, 지경, 해독 등의 효능이 있고, 구기자는 가지과에 속하는 구기자 나무(Lycium chinense)의 성숙 과실로서 채취하여 바람이 잘 부는 음지에서 건조시킨 후 다시 햇볕에 건조시킨 것을 사용하고, 자신, 보간, 윤폐, 자음, 명목 등의 효능이 있다.Phalanx is a deciduous shrub that is a root of the Goji berry tree belonging to the branch family, and has the efficacy of self, interpolation, rotation, consonant, nominal, etc. Hyunsam is a perennial herb and is collected as the root of Scrophularia ningpoensis belonging to the Hyunsam family Remove stems and fine roots, clean them, and dry them in the sun for about 5 days. They are effective for consonant, fortification, cultivation, and detoxification. Goji is collected as mature fruit of Lycium chinense, which belongs to the branch family. After drying in a well-winded shade, and then dried in the sun, using the self, interpolation, rotation, consonant, nominal effect.

복분자는 복분자 딸기의 열매로서 음위, 소변불금에 사용되고, 차전자는 질경이의 씨로서 성질이 차기 때문에 이뇨제로 많이 사용되고 있을 뿐만 아니라 눈병, 설사, 기침 등의 약재로 쓰이며, 형개는 1년생 초본으로서 꿀풀과에 속하는 형개(Schizonepeta tenuifolia)의 전초로서 가을철 꽃이 피어 있고 식물의 푸른 기운이 남아 있을 때 채취하여 햇볕에 건조시키고 화훼 부분을 제거한 것을 사용하며, 발한, 해열, 거풍, 진통, 지혈 등의 효능이 있어 오한발열, 중풍, 풍진 등에 응용되고 있다.Bokbun is the fruit of bokbunja strawberry and is used in the stomach and urinary incontinence. The tea is used as a diuretic because of its nature as a seed of plantain. It is also used as a medicine for eye disease, diarrhea and cough. As an outpost of Schizonepeta tenuifolia belonging to the family, it is used when autumn flowers bloom and the blue energy of the plant is collected, dried in the sun and the flower parts are removed. Efficacy in sweating, fever, wind, pain, and hemostasis It has been applied to chills, fever, rubella, etc.

방풍은 다년생 초본으로 미나리과에 속하는 방풍의 뿌리로서 수확하여 남은 줄기와 세근을 제거하고 흙을 깨끗이 세척하여 햇볕에 건조시킨 것을 사용하며, 해독, 발한, 거풍, 제습, 진통 등의 효능이 있어 감기, 풍병, 신경통, 관절염 등에 자주 응용되고, 녹용은 사슴의 새로 돋은 연한 뿔로 성질이 온하여 피를 돕고 심장을 강하게 하는 힘이 있어 예로부터 보약으로 귀하게 쓰여왔다.Windproof is a perennial herb that is harvested as the root of windproof belonging to the Apiaceae, and removes the remaining stems and roots, cleans the soil, and dry it in the sun.It has the effects of detoxification, sweating, wind, dehumidification, pain relief, It is frequently applied to wind sickness, neuralgia, arthritis, etc., and the deer antler has a new tender horn of deer, which has the power to help blood and strengthen the heart.

녹각은 녹용이 자라서 그 속에 들어 있던 피의 양도 줄고 털도 뻣뻣하게 되어 굳어진 사슴의 뿔로서 약재로 많이 사용되고 있고, 동충하초는 버섯의 일종으로서 누에 번데기 등과 같은 각종 벌레의 번데기등에서 성장한 버섯으로 예로부터 영약으로 알려져 왔으며, 지모는 다년생 초본으로서 지모과에 속하는 지모(Anemarrhena asphodeloides)의 근경으로 채취하여 쑤염뿌리를 제거한 후, 햇볕에 건조시킨 것을 사용하며, 자음, 강화, 윤조, 윤장, 살균 등의 효능이 있는 것이고, 황백은 낙엽교목으로서 운향과에 속하는 황백(Phellodendron amurense)의 근피로서10년 이상된 나무의 겉껍질을 1차로 제거하고 속껍질을 벗기어 말리지 않고 편평하게 되도록 신경쓰면서 햇볕에 건조시킨 것을 사용하며, 해열, 조습, 사화, 살균 등의 효능이 있어 이질, 소갈, 간염, 황달, 적백체하, 목적, 구내염, 활염, 종창 등에 응용한다.Deer antler is used as a medicinal herb as a deer's horn, which reduces the amount of blood and stiff hairs. The cordyceps is a mushroom that grows in the chrysalis of various insects such as silkworm chrysalis. It is known that it is a perennial herb that is collected from the root of Anemarrhena asphodeloides belonging to the genus and removes rhizome roots, and then dried in the sun. Is a deciduous arboreous tree, which is the root of Phellodendron amurense, belonging to the Unhyang family, and is dried first in the sun, taking care not to peel off the bark and flattening it. It is effective in antipyretic, humid, dead, sterilization, dysentery, small brown, hepatitis, jaundice and red white. And, the application purpose, stomatitis, hwalyeom, swelling or the like.

지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백은 각각 3 ∼ 34중량%를 사용하는 것이 효과적이고, 사용량이 3중량% 미만일 경우에는 첨가 효과가 미약하고, 34중량%를 초과할 경우에는 상대적으로 다른성분의 사용량이 감소되어 본 발명에서 얻고자 하는 효과를 달성할 수 없는 문제점이 있다.Gigolpi, Hyunsam, Gugija, Bokbunja, Cha-jeon, Hyeonggae, Windproof, Deer Antler, Green Ginseng, Cordyceps Sinensis, Zimo, and Yellow White, respectively, are effective to use 3 to 34% by weight, and the amount of addition is less than 3% by weight. And, if it exceeds 34% by weight, the amount of other components is relatively reduced, there is a problem that can not achieve the effect to be obtained in the present invention.

상기와 같은 성분들로 본 발명의 성장 호르몬 분비 촉진제를 제조하되 각각의 성분을 세말하여 분말을 균일하게 혼합한 후, 증류수에 침전추출하고 여과한 다음, 감압농축하여 냉각하고 에탄올을 첨가하여 65%에탄을 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 후, 2차감압농축하여 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차감압농축하여 증류수를 첨가하고 감압농축하여 에탄올을 완전히 증발시킨 후, 동결건조하고 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 주사액으로 제조한다.Prepare the growth hormone secretagogue of the present invention with the above components, but finely mix the powder by grinding each component, precipitated and extracted with distilled water, filtered and concentrated under reduced pressure, cooled and added ethanol 65% Ethanol was made into a solution, stirred and left to stand at low temperature, the precipitate was filtered. Secondary pressure was concentrated and cooled. Then, ethanol was added to make 85% ethanol solution. The mixture was stirred and left at low temperature to filter the precipitate. After distilled water was added and concentrated under reduced pressure, ethanol was completely evaporated, lyophilized, dissolved in physiological saline, and then filtered through Millipore filter paper to prepare an injection solution.

분말의 크기는 미세할수록 각각의 성분에서 유효 성분이 용이하게 추출될수 있어 바람직하지만, 경제적인 측면에서 볼 때 320메쉬 정도인 것이 효과적이다.The finer the powder is, the more effective the active ingredient can be easily extracted from each component. However, economically, it is effective to be about 320 mesh.

각각의 성분을 세말하여 분말을 균일하게 혼합한 것 20g을 삼각플라스크에넣고 증류수 1000ml를 가하여 쉐이킹 인큐베이터(shaking incubator)에서 24시간 동안 침전추출하고 여과한 다음, 남은 찌꺼기에 다시 500ml의 증류수를 가하여 쉐이킹 인큐베이터(shaking incubator)에서 24시간 동안 침전추출하고 여과하고 처음의 추출액을 합한 후, 감압농축하여 잔량이 50ml가 되도록 한 다음에 실온까지 냉각하고 에탄올을 첨가하여 65%에탄을 용액으로 만들어 교반하고 저온에서 24시간 방치하여 침전물을 여과한 후, 여액을 2차 감압농축하여 잔량이 50ml가 되도록 한 다음에 실온까지 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음,3차 감압농축하여 잔량이 50ml가 되도록 한 다음, 증류수 50ml를 첨가하고 다시 감압농축하여 잔량이 50ml가 되도록 하여 에탄올을 완전히 증발시킨 후, 동결건조하고 건조엑기스를 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 복강 주사용 주사액 형태로 성장 호르몬 분비 촉진제를 제조한다.Pour each of the ingredients and mix the powder evenly into a Erlenmeyer flask, add 1000 ml of distilled water, precipitate for 24 hours in a shaking incubator, filter, and then shake the remaining residue with 500 ml of distilled water. Precipitate and filter for 24 hours in a shaking incubator, combine the first extract, concentrate under reduced pressure to make the residue 50ml, cool to room temperature, add ethanol to make 65% ethane solution, stir and cool The precipitate was filtered for 24 hours, filtered, and the filtrate was concentrated under a reduced pressure to 50 ml. The residue was cooled to room temperature, cooled to room temperature, ethanol was added to make an 85% ethanol solution, stirred, and the precipitate was filtered at room temperature. Next, concentrate under reduced pressure to make the remaining amount 50ml, add 50ml of distilled water, and depressurize again. And the remaining amount so that chukhayeo 50ml and then completely evaporated ethanol, lyophilized, and the dried extract was filtered as dissolved in physiological saline solution and Millipore filter paper to produce a growth hormone secretagogue by intraperitoneal injection injectable form.

상기와 같은 본 발명의 성장호르몬 분비 촉진용 조성물을 공지의 방법으로 함유 성분들을 추출하여 왜소증 환자에게 장기간 음용하게 하거나 주사액으로 제조된 성장호르몬 분비촉진제를 복강에 주사하게되면 성장호르몬의 분비가 촉진되어 성장호르몬 결핍증 뿐만 아니라 터너증후군, 가족성왜소증 같은 성장호르몬 비결핍성왜소증 환자의 성장을 촉진시킬 수 있게 된다.When the composition for promoting growth hormone secretion of the present invention as described above is extracted in a well-known method to drink for a long time to dwarfism patients or injection of a growth hormone secretagogue prepared as an injection into the abdominal cavity, the secretion of growth hormone is promoted In addition to growth hormone deficiency, it is possible to promote the growth of patients with growth hormone non-deficient dwarfism such as Turner syndrome and familial dwarfism.

본 발명의 조성물 또는 성장호르몬 분비 촉진제는 작용기전이 밝혀지지는 않았지만 다른 증상의 환자에게 상기와 같은 조성물 또는 성장호르몬 분비 촉진제를 투여시 왜소증을 치료할 수 있음이 발견되었다. 특히, 본 발명의 조성물 또는 성장호르몬 분비 촉진제는 사상체질 중 소양인의 체질을 갖는 왜소증 환자에게서 효과적 이었다.Although the composition or growth hormone secretagogue of the present invention is not known mechanism of action, it has been found that the administration of such composition or growth hormone secretagogue to treat dwarfism in patients with other symptoms. In particular, the compositions or growth hormone secretagogues of the present invention were effective in patients with dwarfism who had the nature of Soyangin in filamentous constitution.

다음의 실시예는 본 발명을 좀 더 상세히 설명하는 것이지만, 본 발명의 범주를 한정하는 것은 아니다.The following examples illustrate the invention in more detail, but do not limit the scope of the invention.

실시예 1Example 1

숙지황 16g, 산수유 및 백복령 각 8g, 택사 및 목단피 각 6g, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각4g을 분쇄기에 투입하여 분쇄하여 미세 분말화하고, 균일하게 혼합한 후, 20g을 칭량하여 삼각플라스크에 넣고 증류수 1OOOml를 가하여 쉐이킹 인큐베이터(shaking incubator)에서 24시간 동안 침전추출하고 여과한 다음, 남은 찌꺼기에 다시 500ml의 증류수를 가하여 쉐이킹 인큐베이터(shaking incubator)에서 24시간 동안 침전추출하고 여과하고 처음의 추출액을 합한 후, 감압농축하여 잔량이 50ml가 되도록 한 다음에 실온까지 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 24시간 방치하여 침전물을 여과한 후, 여액을 2차 감압농축하여 잔량이 50ml가 되도록 한 다음에 실온까지 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차 감압농축하여 잔량이 50ml가 되도록 한 다음, 증류수 50ml를 첨가하고 다시 감압농축하여 잔량이 50ml가 되도록 하여 에탄올을 완전히 증발시킨 후, 동결건조하고 건조엑기스를 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 복강 주사용 주사액 형태로 본 발명의 성장호르몬 분비 촉진제를 제조하였다.16g of sujijihwang, 8g each of cornus and Baekbokryeong, 6g each of talc and velvet skin, Jigolpi, Hyunsam, Gugija, Bokbunja, tea electron, hyungae, windbreak, deer antler, green rust, Cordyceps sinensis, jimo and yellow white 4g were put into the grinder and pulverized. After mixing and uniformly mixing, weigh 20 g into a Erlenmeyer flask, add 100 ml of distilled water, precipitate for 24 hours in a shaking incubator, filter, and then add 500 ml of distilled water to the remaining residue again. The precipitate was extracted for 24 hours in a shaking incubator, filtered and the first extract was combined, concentrated under reduced pressure until the remaining amount was 50 ml, cooled to room temperature, added to ethanol to a 65% ethanol solution, stirred, and stirred for 24 hours at low temperature. The precipitate was filtered off, and the filtrate was concentrated under a second reduced pressure so that the remaining amount was 50 ml. Add Ole to make 85% ethanol solution, stir and leave at low temperature to filter the precipitate. Concentrate under reduced pressure to make the residue 50ml, add 50ml of distilled water and concentrate under reduced pressure to make 50ml. After ethanol was completely evaporated, lyophilized, the dried extract was dissolved in physiological saline, and then filtered through Millipore filter paper to prepare a growth hormone secretagogue of the present invention in the form of an injection solution for intraperitoneal injection.

제조된 성장호르몬 분비 촉진제를 흰쥐에 투여하여 효능을 평가하였다.Efficacy was evaluated by administering the prepared growth hormone secretagogue to the rat.

즉, 실험동물로 흰쥐(Sprague-Dawley, male)를 선정 한 후, 출생 일을 제1일로 하여 표준조건(22±/℃, 습도 55±5%)에서 사육한 생후 21일된 체중 25 ∼ 30g의 흰쥐를 선발하였으며, 각각의 실험군을 7 ∼ 8마리로 하여 제조된 성장호르몬 분비촉진제 1.0g/쥐체중kg과 10.0g/쥐체중kg 농도로 각각 생리식염수에 희석한 후, 흰쥐에 각각 복강주사하여 15분 후에 에테르로 마취한 다음, 심장으로 부터 채혈하고 혈청을 분리(3,000rpm,4℃)한 후, 성장호르몬 키트(Growth Hormone kit)를 이용하여 방사선면역 분석법(Radioimmuno Assay)로 감마 카운터(Gamma counter; Packard, Auto Gamma 5550)를 사용하여 정량하므로서 혈청의 성장호르몬 함량을 측정하였다.In other words, after selecting the rat (Sprague-Dawley, male) as the experimental animal, the birth date was the first day of breeding at the standard conditions (22 ± / ℃, humidity 55 ± 5%) of 21 days of age 25 ~ 30g of body weight Rats were selected, and each group was made of 7 to 8 rats. The growth hormone secretagogues 1.0g / kg and 10.0g / kg were respectively diluted in physiological saline and then intraperitoneally injected into the rats. After 15 minutes, anesthesia was performed with ether, blood was collected from the heart, serum was separated (3,000 rpm, 4 ° C.), and the growth hormone kit (Growth Hormone kit) was used for the radioimmuno assay (Radioimmuno Assay). The growth hormone content of the serum was measured by quantification using a counter (Packard, Auto Gamma 5550).

대조군으로 성장호르몬 분비 펩타이드(GHRP)인D-YS-TYR-D-TRP-D-TRP-PHE AMIDE(L4135)는 시그마 케미칼 컴파니(Sigma Chemical Co.(St, Louis, Mo))에서 구입하여 상기의 성장호르몬 분비 촉진제와 동일한 방법으로 복강에 주사하여 성장호르몬 함량을 측정하였다.As a control, growth hormone secreting peptide (GHRP) D- YS-TYR -D - TRP- D - TRP-PHE AMIDE (L4135) was purchased from Sigma Chemical Co. (St, Louis, Mo). The growth hormone content was measured by injection into the abdominal cavity in the same manner as the growth hormone secretagogue.

또한, 상기의 실시예에 있어서 모든 시약은 앨드리치(Aldrich)사로 부터 구입하여 사용하였다.In addition, in the above Example, all the reagents were purchased from Aldrich.

측정된 성장호르몬의 함량을 표 1, 도 1과 도 2에 나타내었다.The measured growth hormone content is shown in Table 1, Figure 1 and Figure 2.

표 1Table 1

*a) : 평균 ± 표준편차a): mean ± standard deviation

NS : 보통 식염수NS: normal saline

GR : GHRPGR: GHRP

SA:본 발명의 성장호르몬 분비 촉진제SA: Growth hormone secretagogue of the present invention

상기 표 1로 부터 알 수 있는 바와 같이 대조군으로 사용한 식염수에 있어서 성장호르몬 함량은 38.6 ± 4.04pg/ml로 나타냈으며, 본 발명의 성장호르몬 분비촉진제를 1.0g/kg, 10g/kg을 복강주사한 실험군은 각각 42.9 ± 5.22pg/ml 및 45.0 ±4.63pg/ml로 나타나 성장호르몬 분비를 촉진시켰다.As can be seen from Table 1, the growth hormone content in the saline solution used as a control group was 38.6 ± 4.04 pg / ml, and the growth hormone secretagogue of the present invention was intraperitoneally injected with 1.0 g / kg and 10 g / kg. Experimental groups were 42.9 ± 5.22 pg / ml and 45.0 ± 4.63 pg / ml, respectively, to promote growth hormone secretion.

실시예 2Example 2

10 ∼ 15세 정도의 사춘기 남학생 중 맥진하여 태음인으로 판단되는 50명의 학생들에게 의이인 및 건율 각 12g, 나복자 6g, 길경, 백문동, 오미자, 석창포, 원지, 천문동, 산조인, 용안육, 녹용, 녹각, 백강잠, 익지인 및 황련 각4g을 분쇄기에 투입하여 분쇄하여 미세 분말화하고, 균일하게 혼합한 후, 20g을 칭량하여 삼각플라스크에 넣고 증류수 1000ml를 가하여 쉐이킹 인큐베이터(shaking incubator)에서 24시간동안 침전추출하고 여과한 다음, 남은 찌꺼기에 다시 500ml의 증류수를 가하여 쉐이킹 인큐베이터(shaking incubator)에서 24시간 동안 침전추출하고 여과하고 처음의 추출액을 합한 후, 감압농축하여 잔량이 50ml가 되도록 한 다음에 실온까지 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 24시간 방치하여 침전물을 여과한 후, 여액을 2차 감압농축하여 잔량이 50ml가 되도록 한 다음에 실온까지 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차 감압농축하여 잔량이 50ml가 되도록 한 다음, 증류수 50ml를 첨가하고 다시 감압농축하여 잔량이 50ml가 되도록 하여 에탄올을 완전히 증발시킨 성장호르몬 분비 촉진제를 6개월에서 1년간 투여하고 성장정도를 측정한 결과, 5cm 이하로 성장한 경우는 14명으로 28%에 해당되었으며, 5 ∼ 9cm를 성장한 경우는 20명으로 40%, 10 ∼ 15cm를 성장한 경우는 15명으로 30%, 15cm 이상 성장한 경우는 1명으로 2%에 해당되었다.50 male students aged 10-15 years old who are determined to be Taeumin by Euiin and dryness 12g, Nagjaja 6g, Gilgyeong, Baekmun-dong, Schisandra, Seokchangpo, Wonji, Cheonmun-dong, Sanjoin, Yonganyuk, Nokyong, Nokgak, Baekgangjam , 4 g each of ripen and rhubarb are added to a grinder, pulverized and finely powdered, mixed uniformly, and weighed 20 g into a Erlenmeyer flask, and 1000 ml of distilled water is added to precipitate and extract for 24 hours in a shaking incubator. After filtration, 500 ml of distilled water was added to the remaining residues again, and the precipitate was extracted for 24 hours in a shaking incubator, filtered, the first extracts were combined, concentrated under reduced pressure to 50 ml, and then cooled to room temperature. Ethanol was added to make 65% ethanol solution, stirred and left at low temperature for 24 hours to filter the precipitate, and then the filtrate was washed with 2 Concentrate under reduced pressure to make the remaining amount 50ml, then cool to room temperature, add ethanol to make 85% ethanol solution, stir and leave at low temperature to filter the precipitate, and then concentrate under reduced pressure to make the remaining amount to 50ml. 50ml of distilled water was added and concentrated under reduced pressure to make the remaining amount 50ml. The growth hormone secretagogue, which was completely evaporated with ethanol, was administered for 6 months to 1 year. In the case of 5-9cm growth, 20 people were 40%, and 10-15cm growth was 15 people, 30%, and more than 15cm growth was 1 person, 2%.

한편, 국립기술품질원이 실시한 1997년 국민체위조사에서 나타난 성장기 청소년의 1년간 성장 평균치는 3.5cm인 바, 본 발명의 성장호르몬 분비 촉진제의 복용시 평균치 이상으로 성장한 경우는 72%에 해당되어 성장에 효과적임을 알 수 있었다.In the meantime, the average growth rate of adolescents during the growth period shown by the National Institute of Technology and Quality in 1997 was 3.5cm, and when the growth hormone secretion stimulant of the present invention was grown above the average value, 72% of the growth occurred. It was found to be effective.

상술한 바와 같이 본 발명에서는 숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피 각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것으로 각각의 성분을 세말하여 분말을 균일하게 혼합한 후, 증류수에 침전추출하고 여과한 다음, 감압농축하여 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 후, 2차감압농축하여 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차감압농축하여 증류수를 첨가하고 감압농축하여 에탄올을 완전히증발시킨 후, 동결건조하고 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 주사액으로 성장호르몬 분비 촉진제를 제조하고 이를 성장기 어린이 또는 왜소증환자에 투여하므로서 성장을 촉진시킬 수 있는 효과를 얻을 수 있었다.As described above, in the present invention, 15 to 46% by weight of Sukjihwang, 5 to 36% by weight of cornus and Baekbokryeong, 4 to 35% by weight of talc and velvet skin, phalanx, hyeonsam, wolfberry, bokbunja, tea, mold, windproof and antler It consists of 3 ~ 34% by weight of green tea, Cordyceps sinensis, hair loss, and yellowish white powder. Mix each powder uniformly, precipitate precipitate in distilled water, filter, concentrate under reduced pressure, cool and add ethanol. It was made into 65% ethanol solution, stirred and left to stand at low temperature to filter the precipitate. The precipitate was concentrated and cooled by secondary pressure reduction, ethanol was added to make it into 85% ethanol solution, stirred, and left to stand at low temperature to filter the precipitate. Concentrated, distilled water was added, concentrated under reduced pressure, ethanol was completely evaporated, lyophilized, dissolved in physiological saline, filtered through millipore filter paper, and grown into injection solution. By preparing a lemonium secretion accelerator and administering it to a growing child or dwarf patients, it was possible to obtain the effect of promoting growth.

Claims (3)

숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것을 특징으로 하는 성장호르몬분비 촉진용 조성물.Hwangji Hwang 15 to 46% by weight, cornus and 5 to 36% by weight of Baekbokryeong, 4 to 35% by weight of talc and vellum, Jigolpi, Hyunsam, Gugija, Bokbunja, teapot, mold opening, windproof, deer antler, green rust, cordyceps, jimo and Growth hormone secretagogue composition, characterized in that composed of 3 to 34% by weight of each white. 숙지황 15 ∼ 46중량%, 산수유 및 백복령 각 5 ∼ 36중량%, 택사 및 목단피각 4 ∼ 35중량%, 지골피, 현삼, 구기자, 복분자, 차전자, 형개, 방풍, 녹용, 녹각, 동충하초, 지모 및 황백 각 3 ∼ 34중량%로 구성되는 것으로 각각의 성분을 세말하여 분말을 균일하게 혼합한 후, 증류수에 침전추출하고 여과한 다음, 감압농축하여 냉각하고 에탄올을 첨가하여 65%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 후, 2차감압농축하여 냉각하고 에탄올을 첨가하여 85%에탄올 용액으로 만들어 교반하고 저온에서 방치하여 침전물을 여과한 다음, 3차감압농축하여 증류수를 첨가하고 감압농축하여 에탄올을 완전히 증발시킨 후, 동결건조하고 생리식염수에 용해한 다음, 밀리포아 여과지로 여과하여 주사액으로 제조하는 것을 특징으로 하는 성장호르몬 분비 촉진제.Hwangji Hwang 15 to 46% by weight, cornus and 5 to 36% by weight of Baekbokryeong, 4 to 35% by weight of talc and vellum, Jigolpi, Hyunsam, Gugija, Bokbunja, teapot, mold opening, windproof, deer antler, green rust, cordyceps, jimo and It consists of 3 to 34% by weight of each white-white powder, and mixes the powders uniformly, precipitates and distills into distilled water, filters, concentrates under reduced pressure, cools, adds ethanol to make 65% ethanol solution, and stirs them. The mixture was left at low temperature, filtered, and the precipitate was concentrated and cooled by secondary depressurization, cooled to 85% ethanol solution by adding ethanol, stirred, and left to stand at low temperature to filter the precipitate. Concentrated and completely evaporated ethanol, lyophilized, dissolved in physiological saline, and filtered by Millipore filter paper to produce a growth hormone, characterized in that the injection solution Secretagogues. 제 2 항에 있어서, 사상체질 중 소양인에게 적용함을 특징으로 하는 성장호르몬 분비 촉진제.The growth hormone secretagogue according to claim 2, characterized in that it is applied to Soyangin in filamentous constitution.
KR1019980020576A 1998-06-03 1998-06-03 Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same KR20000000757A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980020576A KR20000000757A (en) 1998-06-03 1998-06-03 Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980020576A KR20000000757A (en) 1998-06-03 1998-06-03 Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same

Publications (1)

Publication Number Publication Date
KR20000000757A true KR20000000757A (en) 2000-01-15

Family

ID=19538273

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980020576A KR20000000757A (en) 1998-06-03 1998-06-03 Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same

Country Status (1)

Country Link
KR (1) KR20000000757A (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100345752B1 (en) * 2000-06-03 2002-07-27 신준식 Pharmacolocial effect and extracting method for chronic osteoporosis and degenerative bone marrow diseases and rhematoid arthritis treatment by constituent drugs of oriental medicine
KR100358937B1 (en) * 1998-04-23 2003-03-17 주식회사 엘지생명과학 Water-soluble extract of anemarrhena asphodeloides bunge having growth hormone release stimulating activity and growth hormone release stimulating factor separated therefrom
KR20030022655A (en) * 2001-09-10 2003-03-17 (주)내츄럴엔도텍 Pharmaceutical Compositions and Health Foods for Inducing IGF-1 Secretion
KR20030033921A (en) * 2001-10-23 2003-05-01 주식회사 한솔바이오텍 Functional beverage made by herbal medicine that stimulates growth of children
KR100394147B1 (en) * 2000-06-03 2003-08-09 신준식 Pharmacolocial effect and extracting method for chronic osteoporosis and rhematoid arthritis treatment by constituent drugs of oriental medicine
KR20030086158A (en) * 2002-05-03 2003-11-07 (주)메디엔스 Composition for accerating growth
KR20040035985A (en) * 2002-10-14 2004-04-30 (주)에이비아이 Composition for growth promotion by increasing expression of growth hormone and weight gain in quantity
WO2014047321A1 (en) * 2012-09-20 2014-03-27 Quality Ip Holdings, Inc. Compositions and methods for increasing human growth hormone levels
KR101493442B1 (en) * 2014-01-13 2015-02-16 하성미 The extracts concentrate of medical herbs for promoting children and youths growth and method for fabricating the same
US9066953B2 (en) 2012-09-20 2015-06-30 Quality IP Holdings, LLC Methods for increasing endurance and fat metabolism in humans
US9198889B2 (en) 2012-09-19 2015-12-01 Quality IP Holdings, LLC Methods for treating post-traumatic stress disorder
US9238023B2 (en) 2012-09-19 2016-01-19 Quality IP Holdings, LLC Methods for improving health in humans
US9238024B2 (en) 2012-09-20 2016-01-19 Quality IP Holdings, LLC Methods for improving health in canines
US9339490B2 (en) 2012-09-19 2016-05-17 Quality IP Holdings, LLC Methods and compositions for increasing sex steroids and growth hormones
US10292964B2 (en) 2012-09-20 2019-05-21 Quality IP Holdings, LLC Compositions for increasing human growth hormone levels
US10292957B2 (en) 2012-09-20 2019-05-21 Quality IP Holdings, LLC Compositions and methods for treating fibromyalgia
US10300101B2 (en) 2012-09-19 2019-05-28 Quality IP Holdings, LLC Methods and compositions for enhancing or maintaining fertility
KR20190116045A (en) * 2018-04-03 2019-10-14 (주)하늘마음바이오 Method for producing medicine of growth lack
US10894072B2 (en) 2017-02-13 2021-01-19 IP Quality Holdings, LLC Compositions and methods for treating fibromyalgia

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100358937B1 (en) * 1998-04-23 2003-03-17 주식회사 엘지생명과학 Water-soluble extract of anemarrhena asphodeloides bunge having growth hormone release stimulating activity and growth hormone release stimulating factor separated therefrom
KR100394147B1 (en) * 2000-06-03 2003-08-09 신준식 Pharmacolocial effect and extracting method for chronic osteoporosis and rhematoid arthritis treatment by constituent drugs of oriental medicine
KR100345752B1 (en) * 2000-06-03 2002-07-27 신준식 Pharmacolocial effect and extracting method for chronic osteoporosis and degenerative bone marrow diseases and rhematoid arthritis treatment by constituent drugs of oriental medicine
KR20030022655A (en) * 2001-09-10 2003-03-17 (주)내츄럴엔도텍 Pharmaceutical Compositions and Health Foods for Inducing IGF-1 Secretion
KR20030033921A (en) * 2001-10-23 2003-05-01 주식회사 한솔바이오텍 Functional beverage made by herbal medicine that stimulates growth of children
KR20030086158A (en) * 2002-05-03 2003-11-07 (주)메디엔스 Composition for accerating growth
KR20040035985A (en) * 2002-10-14 2004-04-30 (주)에이비아이 Composition for growth promotion by increasing expression of growth hormone and weight gain in quantity
US9238023B2 (en) 2012-09-19 2016-01-19 Quality IP Holdings, LLC Methods for improving health in humans
US10300101B2 (en) 2012-09-19 2019-05-28 Quality IP Holdings, LLC Methods and compositions for enhancing or maintaining fertility
US9339490B2 (en) 2012-09-19 2016-05-17 Quality IP Holdings, LLC Methods and compositions for increasing sex steroids and growth hormones
US9198889B2 (en) 2012-09-19 2015-12-01 Quality IP Holdings, LLC Methods for treating post-traumatic stress disorder
US9238024B2 (en) 2012-09-20 2016-01-19 Quality IP Holdings, LLC Methods for improving health in canines
US9066953B2 (en) 2012-09-20 2015-06-30 Quality IP Holdings, LLC Methods for increasing endurance and fat metabolism in humans
US10292964B2 (en) 2012-09-20 2019-05-21 Quality IP Holdings, LLC Compositions for increasing human growth hormone levels
US10292957B2 (en) 2012-09-20 2019-05-21 Quality IP Holdings, LLC Compositions and methods for treating fibromyalgia
WO2014047321A1 (en) * 2012-09-20 2014-03-27 Quality Ip Holdings, Inc. Compositions and methods for increasing human growth hormone levels
KR101493442B1 (en) * 2014-01-13 2015-02-16 하성미 The extracts concentrate of medical herbs for promoting children and youths growth and method for fabricating the same
US10894072B2 (en) 2017-02-13 2021-01-19 IP Quality Holdings, LLC Compositions and methods for treating fibromyalgia
KR20190116045A (en) * 2018-04-03 2019-10-14 (주)하늘마음바이오 Method for producing medicine of growth lack

Similar Documents

Publication Publication Date Title
KR20000000757A (en) Composition of herb medicine for promting release of growth hormone and promoting agent for release of growth hormone using the same
KR101659516B1 (en) Hair growth natural composition for coating of head skin
KR100586813B1 (en) Extract of herbal mixture and health food for prevention or treatment of osteoporosis
KR101787432B1 (en) Method for manufacturing oriental medicine composition which improves menorrhagia and dysmenorrhea comprising fermented velvet antler and yeast hydrolysate
CN1706463A (en) Medicine for treating women's habitual abortion and threatened abortion
CN105998652A (en) Traditional Chinese medicine composition and application and preparation thereof
Nazim et al. Medicinal values of products and by products of sericulture.
KR100289990B1 (en) Herbal composition for promoting growth hormone secretion and growth hormone secretagogue prepared using the same
KR20190122306A (en) A compound for preventing hair loss and promoting hair growth
KR100601390B1 (en) Anti-Obesity ingredients from medicinal plants and their composition
KR100800359B1 (en) A composition having depilation preventing and trichogenousness effect
KR101681890B1 (en) The herbal mixture extract as an active ingredient for prevention and treatment of osteoporosis composition and its manufacture method
KR20110019569A (en) Composition of health food
KR20150051597A (en) Food Composition for improving liver function containing extract of Arctiumlappa L.
KR100509983B1 (en) Healthy food composition for accelerating growth
KR100609643B1 (en) Herbal medicine composition for the treatment of dermatitis and a method of manufacturing the same
CN102114070B (en) Compound traditional Chinese medicine for treating osteoporosis and preparation method thereof
KR20010106339A (en) A manufactoring process of depilatory made a affected part sprayer and a pill
JP2004321087A (en) Healthy food and method for producing the same
CN101357225A (en) Preparation method of medicine for treating elderly cerebral dysfunction
KR20190116045A (en) Method for producing medicine of growth lack
KR20070107393A (en) Composition for promotion of growth
KR101147288B1 (en) Oral hair growth composition from medical plant extracts and process for preparing thereof
CN115006480B (en) Traditional Chinese medicine composition for treating osteoporosis and preparation method thereof
CN103690660B (en) Traditional Chinese medicine composition for stopping alopecia and regenerating hair and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application